Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Vanguard Health Systems Inc Reaffirms FY 2013 Earnings Guidance
Vanguard Health Systems Inc announced that it is confirming previously issued fiscal 2013 outlook for ranges of projected adjusted EBITDA, projected net income attributable to Vanguard Health Systems, Inc. stockholders and projected diluted earnings per share (EPS). According to I/B/E/S Estimates, analysts are expecting the Company to report EBITDA of $560 million, net income of $65 million and EPS of $0.84 for fiscal 2013.
Latest Developments for Vanguard Health Systems Inc
- Vanguard Health Systems Inc Lowers High End Of Prior FY 2013 EBITDA Guidance To A Range In Line With Analysts' Estimates; Lowers FY 2013 Net Income And EPS Guidance
- Vanguard Health Systems Inc Announces President Change-Form 8-K
- Vanguard Health Systems Inc Reaffirms FY 2013 Earnings Guidance
- Vanguard Health Systems Inc Issues FY 2013 Guidance; EBITDA Guidance Below Analysts' Estimates
- Share this
- Link this
- Digg this
Follow Reuters